Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement
Top Cited Papers
- 7 February 2020
- journal article
- review article
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 16 (3), 223-231
- https://doi.org/10.1007/s12519-020-00343-7
Abstract
Since the outbreak of 2019 novel coronavirus infection (2019-nCoV) in Wuhan City, China, by January 30, 2020, a total of 9692 confirmed cases and 15,238 suspected cases have been reported around 31 provinces or cities in China. Among the confirmed cases, 1527 were severe cases, 171 had recovered and been discharged at home, and 213 died. And among these cases, a total of 28 children aged from 1 month to 17 years have been reported in China. For standardizing prevention and management of 2019-nCoV infections in children, we called up an experts’ committee to formulate this experts’ consensus statement. This statement is based on the Novel Coronavirus Infection Pneumonia Diagnosis and Treatment Standards (the fourth edition) (National Health Committee) and other previous diagnosis and treatment strategies for pediatric virus infections. The present consensus statement summarizes current strategies on diagnosis, treatment, and prevention of 2019-nCoV infection in children.This publication has 17 references indexed in Scilit:
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Global virus outbreaks: Interferons as 1st respondersSeminars in Immunology, 2019
- Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During InfancyScientific Reports, 2018
- Interval-valued probabilistic linguistic term sets in multi-criteria group decision makingInternational Journal of Intelligent Systems, 2018
- Middle East respiratory syndrome coronavirus in childrenSciVee, 2015
- Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational studyInternational Journal of Infectious Diseases, 2014
- The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011Thorax, 2011
- Spirometric findings as predictors of survivalThorax, 2010
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004